BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23118876)

  • 21. PPFIA1 is upregulated in liver metastasis of breast cancer and is a potential poor prognostic indicator of metastatic relapse.
    Yang J; Wu NN; Huang DJ; Luo YC; Huang JZ; He HY; Lu HL; Song WL
    Tumour Biol; 2017 Jul; 39(7):1010428317713492. PubMed ID: 28720060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Discordances in ER, PR, and HER2 between primary breast cancer and brain metastasis.
    Jung J; Lee SH; Park M; Youn JH; Shin SH; Gwak HS; Yoo H
    J Neurooncol; 2018 Apr; 137(2):295-302. PubMed ID: 29260362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accumulation of genetic alterations in brain metastases of sporadic breast carcinomas is associated with reduced survival after metastasis.
    Hampl M; Hampl JA; Schwarz P; Frank S; Hahn M; Schackert G; Saeger HD; Schackert HK
    Invasion Metastasis; 1998-1999; 18(2):81-95. PubMed ID: 10364688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. microRNAs Orchestrate Pathophysiology of Breast Cancer Brain Metastasis: Advances in Therapy.
    Kanchan RK; Siddiqui JA; Mahapatra S; Batra SK; Nasser MW
    Mol Cancer; 2020 Feb; 19(1):29. PubMed ID: 32059676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer.
    Bonneau C; Eliès A; Kieffer Y; Bourachot B; Ladoire S; Pelon F; Hequet D; Guinebretière JM; Blanchet C; Vincent-Salomon A; Rouzier R; Mechta-Grigoriou F
    Breast Cancer Res; 2020 Jul; 22(1):76. PubMed ID: 32665033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subtype switching in breast cancer brain metastases: a multicenter analysis.
    Hulsbergen AFC; Claes A; Kavouridis VK; Ansaripour A; Nogarede C; Hughes ME; Smith TR; Brastianos PK; Verhoeff JJC; Lin NU; Broekman MLD
    Neuro Oncol; 2020 Aug; 22(8):1173-1181. PubMed ID: 31970416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of stromal PDGFR-β and α-SMA expression and their clinical relevance in brain metastases of breast cancer patients.
    Akanda MR; Ahn EJ; Kim YJ; Salam SMA; Noh MG; Lee TK; Kim SS; Lee KH; Moon KS
    BMC Cancer; 2023 May; 23(1):468. PubMed ID: 37217880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Multidisciplinary Breast Cancer Brain Metastases Clinic: The University of North Carolina Experience.
    McKee MJ; Keith K; Deal AM; Garrett AL; Wheless AA; Green RL; Benbow JM; Dees EC; Carey LA; Ewend MG; Anders CK; Zagar TM
    Oncologist; 2016 Jan; 21(1):16-20. PubMed ID: 26659221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancer.
    Hashemi-Sadraei N; Müller-Greven GM; Abdul-Karim FW; Ulasov I; Downs-Kelly E; Burgett ME; Lauko A; Qadan MA; Weil RJ; Ahluwalia MS; Du L; Prayson RA; Chao ST; Budd TG; Barnholtz-Sloan J; Nowacki AS; Keri RA; Gladson CL
    J Neurooncol; 2018 Nov; 140(2):237-248. PubMed ID: 30094720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of KCNMA1 gene in breast cancer invasion and metastasis to brain.
    Khaitan D; Sankpal UT; Weksler B; Meister EA; Romero IA; Couraud PO; Ningaraj NS
    BMC Cancer; 2009 Jul; 9():258. PubMed ID: 19640305
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
    Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
    Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidemiology and economic burden of brain metastases among patients with primary breast cancer: results from a US claims data analysis.
    Pelletier EM; Shim B; Goodman S; Amonkar MM
    Breast Cancer Res Treat; 2008 Mar; 108(2):297-305. PubMed ID: 17577662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Loss of heterozygosity for chromosome 11 in primary human breast tumors is associated with poor survival after metastasis.
    Winqvist R; Hampton GM; Mannermaa A; Blanco G; Alavaikko M; Kiviniemi H; Taskinen PJ; Evans GA; Wright FA; Newsham I
    Cancer Res; 1995 Jun; 55(12):2660-4. PubMed ID: 7780982
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A retrospective analysis of clinic-pathological characteristics and prognostic factor for 137 cases of breast cancer brain metastasis].
    Gao YC; Liu H; Lu S; Zhuang XR; Wang YX; Wang T; Wu YY; Chen MX
    Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):30-4. PubMed ID: 23578424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADAM22/LGI1 complex as a new actionable target for breast cancer brain metastasis.
    Charmsaz S; Doherty B; Cocchiglia S; Varešlija D; Marino A; Cosgrove N; Marques R; Priedigkeit N; Purcell S; Bane F; Bolger J; Byrne C; O'Halloran PJ; Brett F; Sheehan K; Brennan K; Hopkins AM; Keelan S; Jagust P; Madden S; Martinelli C; Battaglini M; Oesterreich S; Lee AV; Ciofani G; Hill ADK; Young LS
    BMC Med; 2020 Nov; 18(1):349. PubMed ID: 33208158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Checkpoint Inhibitors in the Treatment of Breast Cancer Brain Metastases.
    Schlam I; Gatti-Mays ME
    Oncologist; 2022 Jul; 27(7):538-547. PubMed ID: 35598254
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of clinical parameters influencing the development of bone metastasis in breast cancer.
    Diessner J; Wischnewsky M; Stüber T; Stein R; Krockenberger M; Häusler S; Janni W; Kreienberg R; Blettner M; Schwentner L; Wöckel A; Bartmann C
    BMC Cancer; 2016 May; 16():307. PubMed ID: 27175930
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic patterns of allelic imbalance in disease free tissue adjacent to primary breast carcinomas.
    Ellsworth DL; Ellsworth RE; Love B; Deyarmin B; Lubert SM; Mittal V; Shriver CD
    Breast Cancer Res Treat; 2004 Nov; 88(2):131-9. PubMed ID: 15564796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic clonal remodelling in breast cancer metastases is associated with subtype conversion.
    Lluch A; González-Angulo AM; Casadevall D; Eterovic AK; Martínez de Dueñas E; Zheng X; Guerrero-Zotano Á; Liu S; Pérez R; Chen K; Chacón JI; Mills GB; Antolín S; Blancas I; López-Serra P; Carrasco E; Caballero R; Prat A; Rojo F; Gonzalez-Perez A; Meric-Bernstam F; Albanell J
    Eur J Cancer; 2019 Oct; 120():54-64. PubMed ID: 31491604
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.